サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1767755

術後疼痛管理の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）

Postoperative Pain Management Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

出版日
ページ情報
英文 193 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
術後疼痛管理の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2032年）
出版日: 2025年07月09日
発行: Persistence Market Research
ページ情報: 英文 193 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な調査結果

  • 術後疼痛管理の市場規模：451億3,000万米ドル（2025年）
  • 予測される市場金額：652億2,000万米ドル（2032年）
  • 世界市場の成長率：5.4%（2025年～2032年のCAGR）

術後疼痛管理市場 - レポート範囲

術後疼痛管理は、外科手術後の患者の回復と転帰の向上に重要な役割を果たします。この市場には、鎮痛薬（オピオイド、非オピオイド）、局所麻酔技術、患者管理鎮痛機器、非薬理学的介入など、幅広い製品と治療法が含まれます。術後疼痛管理市場は、病院、手術センター、外来患者を対象としており、痛みの強さを軽減し、オピオイドの使用を最小化し、患者の快適性と満足度を高めることを目的としたソリューションを提供しています。市場成長の促進要因は、世界中での外科手術の増加、効果的な疼痛管理プロトコルに対する意識の高まり、ドラッグデリバリーと疼痛モニタリング技術の革新です。

市場成長の促進要因

世界の術後疼痛管理市場は、高齢化による外科手術件数の増加や慢性疾患の流行などの複数の要因に後押しされています。効果的な疼痛制御の重要性やオピオイドの過剰使用に伴うリスクに対する医療従事者の意識の高まりが、代替の複合的な疼痛管理アプローチへの需要をさらに高めています。新しい薬剤の製法、徐放性鎮痛薬、スマートな患者管理鎮痛機器などの技術の進歩は、治療の有効性と安全性の向上に寄与しています。さらに、術後回復強化（ERAS）プロトコルを推進する政府の取り組みや臨床ガイドラインも市場拡大を後押ししています。

市場抑制要因

有望な成長が見込まれる一方、術後疼痛管理市場は、オピオイド中毒の懸念、厳しい規制要件、先進の疼痛管理療法に関連する高いコストといった課題に直面しています。特定の鎮痛薬に関連する副作用や合併症のリスクが、その普及を制限しています。さらに、償還政策に一貫性がなく、地域間で疼痛管理プロトコルが標準化されていないことも、特に新興経済諸国では市場浸透の障壁となっています。

市場機会

術後疼痛管理市場は、研究開発投資の増加、非オピオイド鎮痛薬の採用の拡大、局所麻酔技術の使用の拡大などにより、大きな成長機会を示しています。医療インフラと外科治療へのアクセスが拡大している新興市場は、未開発の可能性を秘めています。疼痛モニタリングと個別化された疼痛管理戦略に向けたデジタルヘルスツールの統合は、患者の転帰と市場成長をさらに高める可能性があります。革新的で費用対効果の高い患者中心の疼痛管理ソリューションを開発するには、製薬企業、医療機器メーカー、医療提供者の戦略的提携が不可欠です。

当レポートでは、世界の術後疼痛管理市場について調査し、成長促進要因、動向、機会、課題などの市場力学の詳細な分析を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主要動向
  • マクロ経済要因
    • 世界の部門の見通し
    • 世界のGDP成長の見通し
  • COVID-19の影響の分析
  • 予測要因 - 関連性と影響

第3章 付加価値考察

  • 規制情勢
  • 製品採用分析
  • バリューチェーン分析
  • 主な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 世界の術後疼痛管理市場の見通し

  • 主なハイライト
    • 市場規模と前年比成長
    • 絶対的収益機会
  • 市場規模の分析と予測
    • 市場規模の実績の分析（2019年～2024年）
    • 市場規模の分析と予測（2025年～2032年）
  • 世界の術後疼痛管理市場の見通し：医薬品
    • イントロダクション/主な調査結果
    • 市場規模の実績：医薬品別（2019年～2024年）
    • 市場規模の分析と予測：医薬品別（2025年～2032年）
      • オピオイド
        • トラマドール
        • オキシコドン
        • ヒドロコドン
        • その他のオピオイド
      • NSAIDs
      • 局所麻酔薬
      • アセトアミノフェン
    • 市場の魅力分析：医薬品
  • 世界の術後疼痛管理市場の見通し：投与経路
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：投与経路別（2019年～2024年）
    • 市場規模の分析と予測：投与経路別（2025年～2032年）
      • 注射
      • 経口
      • 経腸
      • 外用
      • 経皮
      • その他
    • 市場の魅力分析：投与経路
  • 世界の術後疼痛管理市場の見通し：処方タイプ
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：処方タイプ別（2019年～2024年）
    • 市場規模の分析と予測：処方タイプ別（2025年～2032年）
      • OTC製品
      • 処方薬
    • 市場の魅力分析：処方タイプ
  • 世界の術後疼痛管理市場の見通し：流通チャネル
    • イントロダクション/主な調査結果
    • 市場規模の実績の分析：流通チャネル別（2019年～2024年）
    • 市場規模の分析と予測：流通チャネル別（2025年～2032年）
      • 病院薬局
      • 専門クリニック
      • 長期ケアセンター
      • 小売薬局
      • ドラッグストア
      • オンライン薬局
    • 市場の魅力分析：流通チャネル

第5章 世界の術後疼痛管理市場の見通し：地域

  • 主なハイライト
  • 市場規模の実績の分析：地域別（2019年～2024年）
  • 市場規模の分析と予測：地域別（2025年～2032年）
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第6章 北米の術後疼痛管理市場の見通し

第7章 欧州の術後疼痛管理市場の見通し

第8章 東アジアの術後疼痛管理市場の見通し

第9章 南アジア・オセアニアの術後疼痛管理市場の見通し

第10章 ラテンアメリカの術後疼痛管理市場の見通し

第11章 中東・アフリカの術後疼痛管理市場の見通し

第12章 競合情勢

  • 市場シェア分析（2025年）
  • 市場構造
    • 競合強度マップ：市場別
    • 競合ダッシュボード
  • 企業プロファイル（詳細 - 概要、財務、戦略、近年の発展）
    • Teva Pharmaceutical Industries Ltd
    • Novartis AG
    • Allergan plc
    • GlaxoSmithKline plc
    • Mylan NV
    • Johnson & Johnson
    • Pfizer Inc.
    • Purdue Pharma LP
    • Janssen Pharmaceuticals, Inc
    • Endo International plc
    • Baxter International
    • Pacira Pharmaceuticals Inc.
    • Cadila Healthcare Limited
    • Cipla Limited
    • Eisan
    • LG Chem
    • AbbVie Inc.
    • Amgen Inc.
    • Sun Pharmaceutical Ltd.

第13章 付録

目次
Product Code: PMRREP24259

Persistence Market Research has recently released a comprehensive report on the worldwide market for postoperative pain management. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global postoperative pain management market from 2025 to 2032.

Key Insights:

  • Postoperative Pain Management Market Size (2025E): USD 45.13 Billion
  • Projected Market Value (2032F): USD 65.22 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.4%

Postoperative Pain Management Market - Report Scope:

Postoperative pain management plays a crucial role in improving patient recovery and outcomes following surgical procedures. This market includes a wide range of products and therapies such as analgesics (opioids and non-opioids), regional anesthesia techniques, patient-controlled analgesia devices, and non-pharmacological interventions. The postoperative pain management market caters to hospitals, surgical centers, and outpatient care settings, providing solutions that aim to reduce pain intensity, minimize opioid use, and enhance patient comfort and satisfaction. Market growth is driven by increasing surgical procedures worldwide, rising awareness of effective pain management protocols, and innovations in drug delivery and pain monitoring technologies.

Market Growth Drivers:

The global postoperative pain management market is propelled by several key factors, including the rising volume of surgical procedures due to aging populations and growing prevalence of chronic diseases. Increasing awareness among healthcare providers about the importance of effective pain control and the risks associated with opioid overuse further fuel demand for alternative and multimodal pain management approaches. Technological advancements, such as novel drug formulations, extended-release analgesics, and smart patient-controlled analgesia devices, contribute to improving treatment efficacy and safety. Moreover, government initiatives and clinical guidelines promoting enhanced recovery after surgery (ERAS) protocols support market expansion.

Market Restraints:

Despite promising growth prospects, the postoperative pain management market faces challenges related to opioid addiction concerns, stringent regulatory requirements, and high costs associated with advanced pain management therapies. The risk of adverse effects and complications linked to certain analgesics limits their widespread adoption. Additionally, inconsistent reimbursement policies and lack of standardized pain management protocols across regions pose barriers to market penetration, especially in developing economies.

Market Opportunities:

The postoperative pain management market presents significant growth opportunities driven by increasing investments in research and development, rising adoption of non-opioid analgesics, and expanding use of regional anesthesia techniques. Emerging markets with growing healthcare infrastructure and surgical care access offer untapped potential. Integration of digital health tools for pain monitoring and personalized pain management strategies can further enhance patient outcomes and market growth. Strategic collaborations between pharmaceutical companies, medical device manufacturers, and healthcare providers are essential to develop innovative, cost-effective, and patient-centric pain management solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the postoperative pain management market globally?
  • Which types of analgesics and pain management techniques are gaining prominence across various healthcare settings?
  • How are technological advancements influencing treatment protocols and patient outcomes in postoperative pain management?
  • Who are the key players contributing to the postoperative pain management market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global postoperative pain management market?

Competitive Intelligence and Business Strategy:

These companies invest in developing advanced analgesic formulations, non-opioid alternatives, and smart drug delivery systems tailored to diverse patient needs. Collaborations with healthcare providers and research institutions facilitate clinical validation and market access. Emphasis on patient education, safety, and evidence-based protocols fosters market growth and enhances patient outcomes in the evolving postoperative pain management landscape.

Key Companies Profiled:

  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Allergan plc
  • GlaxoSmithKline plc
  • Mylan N.V.
  • Johnson & Johnson
  • Pfizer Inc.
  • Purdue Pharma L.P
  • Janssen Pharmaceuticals, Inc
  • Endo International plc
  • Baxter International
  • Pacira Pharmaceuticals Inc.
  • Cadila Healthcare Limited
  • Cipla Limited
  • Eisan
  • LG Chem
  • AbbVie Inc.
  • Amgen Inc.
  • Sun Pharmaceutical Ltd.

Postoperative Pain Management Market Research Segmentation:

The postoperative pain management market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various surgical procedures and patient populations.

By Drug

  • Opioids
  • Tramadol
  • Oxycodone
  • Hydrocodone
  • Other Opioids
  • NSAIDs
  • Local Anesthetics
  • Acetaminophen

By Route of Administration

  • Injectable
  • Oral
  • Rectal
  • Topical
  • Transdermal
  • Others

By Prescription Type

  • Over-the-counter (OTC) Products
  • Prescription Drugs

By Distribution Channel

  • Hospital Pharmacies
  • Specialty Clinics
  • Long Term Care Centers
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Postoperative Pain Management Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Postoperative Pain Management Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Postoperative Pain Management Market Outlook: Drug
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Drug, 2019-2024
    • 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
      • 4.3.3.1. Opioids
        • 4.3.3.1.1. Tramadol
        • 4.3.3.1.2. Oxycodone
        • 4.3.3.1.3. Hydrocodone
        • 4.3.3.1.4. Other Opioids
      • 4.3.3.2. NSAIDs
      • 4.3.3.3. Local Anesthetics
      • 4.3.3.4. Acetaminophen
    • 4.3.4. Market Attractiveness Analysis: Drug
  • 4.4. Global Postoperative Pain Management Market Outlook: Route of Administration
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019-2024
    • 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      • 4.4.3.1. Injectable
      • 4.4.3.2. Oral
      • 4.4.3.3. Rectal
      • 4.4.3.4. Topical
      • 4.4.3.5. Transdermal
      • 4.4.3.6. Others
    • 4.4.4. Market Attractiveness Analysis: Route of Administration
  • 4.5. Global Postoperative Pain Management Market Outlook: Prescription Type
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Prescription Type, 2019-2024
    • 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
      • 4.5.3.1. Over-The-Counter (OTC) Products
      • 4.5.3.2. Prescription Drugs
    • 4.5.4. Market Attractiveness Analysis: Prescription Type
  • 4.6. Global Postoperative Pain Management Market Outlook: Distribution Channel
    • 4.6.1. Introduction / Key Findings
    • 4.6.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
    • 4.6.3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      • 4.6.3.1. Hospital Pharmacies
      • 4.6.3.2. Specialty Clinics
      • 4.6.3.3. Long Term Care Centers
      • 4.6.3.4. Retail Pharmacies
      • 4.6.3.5. Drug Stores
      • 4.6.3.6. Online Pharmacies
    • 4.6.4. Market Attractiveness Analysis: Distribution Channel

5. Global Postoperative Pain Management Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Postoperative Pain Management Market Outlook

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Drug
    • 6.2.3. By Route of Administration
    • 6.2.4. By Prescription Type
    • 6.2.5. By Distribution Channel
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 6.4.1. Opioids
      • 6.4.1.1. Tramadol
      • 6.4.1.2. Oxycodone
      • 6.4.1.3. Hydrocodone
      • 6.4.1.4. Other Opioids
    • 6.4.2. NSAIDs
    • 6.4.3. Local Anesthetics
    • 6.4.4. Acetaminophen
  • 6.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 6.5.1. Injectable
    • 6.5.2. Oral
    • 6.5.3. Rectal
    • 6.5.4. Topical
    • 6.5.5. Transdermal
    • 6.5.6. Others
  • 6.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 6.6.1. Over-The-Counter (OTC) Products
    • 6.6.2. Prescription Drugs
  • 6.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 6.7.1. Hospital Pharmacies
    • 6.7.2. Specialty Clinics
    • 6.7.3. Long Term Care Centers
    • 6.7.4. Retail Pharmacies
    • 6.7.5. Drug Stores
    • 6.7.6. Online Pharmacies
  • 6.8. Market Attractiveness Analysis

7. Europe Postoperative Pain Management Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Drug
    • 7.2.3. By Route of Administration
    • 7.2.4. By Prescription Type
    • 7.2.5. By Distribution Channel
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Rest of Europe
  • 7.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 7.4.1. Opioids
      • 7.4.1.1. Tramadol
      • 7.4.1.2. Oxycodone
      • 7.4.1.3. Hydrocodone
      • 7.4.1.4. Other Opioids
    • 7.4.2. NSAIDs
    • 7.4.3. Local Anesthetics
    • 7.4.4. Acetaminophen
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 7.5.1. Injectable
    • 7.5.2. Oral
    • 7.5.3. Rectal
    • 7.5.4. Topical
    • 7.5.5. Transdermal
    • 7.5.6. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 7.6.1. Over-The-Counter (OTC) Products
    • 7.6.2. Prescription Drugs
  • 7.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 7.7.1. Hospital Pharmacies
    • 7.7.2. Specialty Clinics
    • 7.7.3. Long Term Care Centers
    • 7.7.4. Retail Pharmacies
    • 7.7.5. Drug Stores
    • 7.7.6. Online Pharmacies
  • 7.8. Market Attractiveness Analysis

8. East Asia Postoperative Pain Management Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Drug
    • 8.2.3. By Route of Administration
    • 8.2.4. By Prescription Type
    • 8.2.5. By Distribution Channel
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 8.4.1. Opioids
      • 8.4.1.1. Tramadol
      • 8.4.1.2. Oxycodone
      • 8.4.1.3. Hydrocodone
      • 8.4.1.4. Other Opioids
    • 8.4.2. NSAIDs
    • 8.4.3. Local Anesthetics
    • 8.4.4. Acetaminophen
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 8.5.1. Injectable
    • 8.5.2. Oral
    • 8.5.3. Rectal
    • 8.5.4. Topical
    • 8.5.5. Transdermal
    • 8.5.6. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 8.6.1. Over-The-Counter (OTC) Products
    • 8.6.2. Prescription Drugs
  • 8.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 8.7.1. Hospital Pharmacies
    • 8.7.2. Specialty Clinics
    • 8.7.3. Long Term Care Centers
    • 8.7.4. Retail Pharmacies
    • 8.7.5. Drug Stores
    • 8.7.6. Online Pharmacies
  • 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Postoperative Pain Management Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Drug
    • 9.2.3. By Route of Administration
    • 9.2.4. By Prescription Type
    • 9.2.5. By Distribution Channel
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 9.4.1. Opioids
      • 9.4.1.1. Tramadol
      • 9.4.1.2. Oxycodone
      • 9.4.1.3. Hydrocodone
      • 9.4.1.4. Other Opioids
    • 9.4.2. NSAIDs
    • 9.4.3. Local Anesthetics
    • 9.4.4. Acetaminophen
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 9.5.1. Injectable
    • 9.5.2. Oral
    • 9.5.3. Rectal
    • 9.5.4. Topical
    • 9.5.5. Transdermal
    • 9.5.6. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 9.6.1. Over-The-Counter (OTC) Products
    • 9.6.2. Prescription Drugs
  • 9.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 9.7.1. Hospital Pharmacies
    • 9.7.2. Specialty Clinics
    • 9.7.3. Long Term Care Centers
    • 9.7.4. Retail Pharmacies
    • 9.7.5. Drug Stores
    • 9.7.6. Online Pharmacies
  • 9.8. Market Attractiveness Analysis

10. Latin America Postoperative Pain Management Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Drug
    • 10.2.3. By Route of Administration
    • 10.2.4. By Prescription Type
    • 10.2.5. By Distribution Channel
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 10.4.1. Opioids
      • 10.4.1.1. Tramadol
      • 10.4.1.2. Oxycodone
      • 10.4.1.3. Hydrocodone
      • 10.4.1.4. Other Opioids
    • 10.4.2. NSAIDs
    • 10.4.3. Local Anesthetics
    • 10.4.4. Acetaminophen
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 10.5.1. Injectable
    • 10.5.2. Oral
    • 10.5.3. Rectal
    • 10.5.4. Topical
    • 10.5.5. Transdermal
    • 10.5.6. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 10.6.1. Over-The-Counter (OTC) Products
    • 10.6.2. Prescription Drugs
  • 10.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 10.7.1. Hospital Pharmacies
    • 10.7.2. Specialty Clinics
    • 10.7.3. Long Term Care Centers
    • 10.7.4. Retail Pharmacies
    • 10.7.5. Drug Stores
    • 10.7.6. Online Pharmacies
  • 10.8. Market Attractiveness Analysis

11. Middle East & Africa Postoperative Pain Management Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Drug
    • 11.2.3. By Route of Administration
    • 11.2.4. By Prescription Type
    • 11.2.5. By Distribution Channel
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Market Size (US$ Bn) Analysis and Forecast, By Drug, 2025-2032
    • 11.4.1. Opioids
      • 11.4.1.1. Tramadol
      • 11.4.1.2. Oxycodone
      • 11.4.1.3. Hydrocodone
      • 11.4.1.4. Other Opioids
    • 11.4.2. NSAIDs
    • 11.4.3. Local Anesthetics
    • 11.4.4. Acetaminophen
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
    • 11.5.1. Injectable
    • 11.5.2. Oral
    • 11.5.3. Rectal
    • 11.5.4. Topical
    • 11.5.5. Transdermal
    • 11.5.6. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By Prescription Type, 2025-2032
    • 11.6.1. Over-The-Counter (OTC) Products
    • 11.6.2. Prescription Drugs
  • 11.7. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
    • 11.7.1. Hospital Pharmacies
    • 11.7.2. Specialty Clinics
    • 11.7.3. Long Term Care Centers
    • 11.7.4. Retail Pharmacies
    • 11.7.5. Drug Stores
    • 11.7.6. Online Pharmacies
  • 11.8. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Teva Pharmaceutical Industries Ltd
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Novartis AG
    • 12.3.3. Allergan plc
    • 12.3.4. GlaxoSmithKline plc
    • 12.3.5. Mylan N.V.
    • 12.3.6. Johnson & Johnson
    • 12.3.7. Pfizer Inc.
    • 12.3.8. Purdue Pharma L.P
    • 12.3.9. Janssen Pharmaceuticals, Inc
    • 12.3.10. Endo International plc
    • 12.3.11. Baxter International
    • 12.3.12. Pacira Pharmaceuticals Inc.
    • 12.3.13. Cadila Healthcare Limited
    • 12.3.14. Cipla Limited
    • 12.3.15. Eisan
    • 12.3.16. LG Chem
    • 12.3.17. AbbVie Inc.
    • 12.3.18. Amgen Inc.
    • 12.3.19. Sun Pharmaceutical Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations